TOKE vs. IBRN ETF Comparison
Comparison of Cambria Cannabis ETF (TOKE) to iShares Neuroscience and Healthcare ETF (IBRN)
TOKE
Cambria Cannabis ETF
TOKE Description
The investment seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry. Under normal market conditions, at least 80% of the value of the fund’s net assets (plus borrowings for investment purposes) will be invested in Cannabis Companies. The Advisor generally expects to invest in Cannabis Companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.
Grade (RS Rating)
Last Trade
$5.44
Average Daily Volume
24,269
11
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$26.50
Average Daily Volume
367
9
Performance
| Period | TOKE | IBRN |
|---|---|---|
| 30 Days | -12.23% | -1.47% |
| 60 Days | -9.33% | 5.71% |
| 90 Days | -9.46% | 1.28% |
| 12 Months | 2.27% | 26.59% |
0 Overlapping Holdings
| Symbol | Grade | Weight in TOKE | Weight in IBRN | Overlap |
|---|
TOKE: Top Represented Industries & Keywords
IBRN: Top Represented Industries & Keywords
Compare ETFs
